Stay updated with breaking news from Alanh Auerbach. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com downgraded shares of Puma Biotechnology (NASDAQ:PBYI – Get Rating) from a buy rating to a hold rating in a report released on Thursday. Separately, HC Wainwright reaffirmed a buy rating and issued a $8.00 price objective on shares of Puma Biotechnology in a research report on Monday, March 6th. Puma Biotechnology Price Performance NASDAQ […]
StockNews.com downgraded shares of Puma Biotechnology (NASDAQ:PBYI – Get Rating) from a buy rating to a hold rating in a report issued on Thursday morning. Separately, HC Wainwright reaffirmed a buy rating and issued a $8.00 price target on shares of Puma Biotechnology in a report on Monday, March 6th. Puma Biotechnology Stock Performance PBYI […]
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that the results of the Phase II TBCRC041 randomized clinical trial of alisertib alone or in combination with fulvestrant in patients with endocrine-resistant advanced breast cancer have been published onlin...
$ million Gross to Net Adjustment 19% - 20% 21% - 21.5% Conference Call Puma Biotechnology will host a conference call to report its fourth quarter and full year 2022 financial results... | March 2, 2023
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, presented updated findings from the Translational Breast Cancer Research Consortium (TBCRC) Trial 022 at the ongoing 2022 San Antonio Breast Cancer Symposium in San Antonio, Texas. The poster (PD7-03), entitled “Nerat...